Literature DB >> 29870684

The binding of TBK1 to STING requires exocytic membrane traffic from the ER.

Emari Ogawa1, Kojiro Mukai1, Kota Saito2, Hiroyuki Arai3, Tomohiko Taguchi4.   

Abstract

Stimulator of interferon genes (STING) is essential for the type I interferon and pro-inflammatory responses against DNA pathogens. In response to the presence of cytosolic DNA, STING translocates from the endoplasmic reticulum (ER) to the Golgi, and activates TANK-binding kinase 1 (TBK1), a cytosolic kinase that is essential for the activation of STING-dependent downstream signalling. The organelles where TBK1 binds to STING remain unknown. Here we show that TBK1 binds to STING at the Golgi, not at the ER. Treatment with brefeldin A, an agent to block ER-to-Golgi traffic, or knockdown of Sar1, a small GTPase that regulates coat protein complex II (COP-II)-mediated ER-to-Golgi traffic, inhibited the binding of TBK1 to STING. Endogenous TBK1 was recruited to the Golgi when STING was transported to the Golgi, as shown by immunofluorescence microscopy. STING variants that constitutively induce the type I interferon response were found in patients with autoinflammatory diseases. Even these disease-causative STING variants could not bind to TBK1 when the STING variants were trapped in the ER. These results demonstrate that the Golgi is an organelle at which STING recruits and activates TBK1 for triggering the STING-dependent type I interferon response.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Autoinflammatory disease; Endoplasmic reticulum; Membrane traffic; STING; TBK1; The Golgi

Mesh:

Substances:

Year:  2018        PMID: 29870684     DOI: 10.1016/j.bbrc.2018.05.199

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  20 in total

Review 1.  STING pathway agonism as a cancer therapeutic.

Authors:  Blake A Flood; Emily F Higgs; Shuyin Li; Jason J Luke; Thomas F Gajewski
Journal:  Immunol Rev       Date:  2019-07       Impact factor: 12.988

2.  UFL1 promotes antiviral immune response by maintaining STING stability independent of UFMylation.

Authors:  Yijie Tao; Shulei Yin; Yang Liu; Chunzhen Li; Yining Chen; Dan Han; Jingyi Huang; Sheng Xu; Zui Zou; Yizhi Yu
Journal:  Cell Death Differ       Date:  2022-07-23       Impact factor: 12.067

3.  The chromatin remodeling protein ATRX positively regulates IRF3-dependent type I interferon production and interferon-induced gene expression.

Authors:  Anne-Charlotte Stilp; Myriam Scherer; Patrick König; Axel Fürstberger; Hans A Kestler; Thomas Stamminger
Journal:  PLoS Pathog       Date:  2022-08-08       Impact factor: 7.464

Review 4.  T-Cell Repertoire in Tumor Radiation: The Emerging Frontier as a Radiotherapy Biomarker.

Authors:  Constantin N Baxevanis; Angelos D Gritzapis; Ioannis F Voutsas; Panagiota Batsaki; Maria Goulielmaki; Maria Adamaki; Vassilios Zoumpourlis; Sotirios P Fortis
Journal:  Cancers (Basel)       Date:  2022-05-27       Impact factor: 6.575

Review 5.  Organellar homeostasis and innate immune sensing.

Authors:  Cassandra R Harapas; Elina Idiiatullina; Mahmoud Al-Azab; Katja Hrovat-Schaale; Thomas Reygaerts; Annemarie Steiner; Pawat Laohamonthonkul; Sophia Davidson; Chien-Hsiung Yu; Lee Booty; Seth L Masters
Journal:  Nat Rev Immunol       Date:  2022-02-23       Impact factor: 108.555

Review 6.  STING-Mediated Lung Inflammation and Beyond.

Authors:  Marie-Louise Frémond; Yanick J Crow
Journal:  J Clin Immunol       Date:  2021-02-02       Impact factor: 8.317

Review 7.  Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy.

Authors:  Kyle M Garland; Taylor L Sheehy; John T Wilson
Journal:  Chem Rev       Date:  2022-02-02       Impact factor: 60.622

8.  Attenuation of cGAS/STING activity during mitosis.

Authors:  Brittany L Uhlorn; Eduardo R Gamez; Shuaizhi Li; Samuel K Campos
Journal:  Life Sci Alliance       Date:  2020-07-13

Review 9.  STING palmitoylation as a therapeutic target.

Authors:  Anne Louise Hansen; Kojiro Mukai; Francisco J Schopfer; Tomohiko Taguchi; Christian K Holm
Journal:  Cell Mol Immunol       Date:  2019-02-22       Impact factor: 11.530

10.  STEEP mediates STING ER exit and activation of signaling.

Authors:  Ramya Nandakumar; Line S Reinert; Bao-Cun Zhang; Jinrong Huang; Anders Laustsen; Zong-Liang Gao; Cheng-Long Sun; Søren Beck Jensen; Anne Troldborg; Sonia Assil; Martin F Berthelsen; Carsten Scavenius; Yan Zhang; Samuel J Windross; David Olagnier; Thaneas Prabakaran; Chiranjeevi Bodda; Ryo Narita; Yujia Cai; Cong-Gang Zhang; Harald Stenmark; Christine M Doucet; Takeshi Noda; Zheng Guo; Raphaela Goldbach-Mansky; Rune Hartmann; Zhijian J Chen; Jan J Enghild; Rasmus O Bak; Martin K Thomsen; Søren R Paludan
Journal:  Nat Immunol       Date:  2020-07-20       Impact factor: 25.606

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.